Prosecution Insights
Last updated: September 17, 2026
Application No. 18/919,199

METHOD RELATING TO PULMONARY HYPERTENSION

Non-Final OA §101§112
Filed
Oct 17, 2024
Priority
Oct 20, 2023 — EU 23204781.1
Examiner
JANG, ELINA SOHYUN
Art Unit
Tech Center
Assignee
Alexander Zorn
OA Round
1 (Non-Final)
69%
Grant Probability
Favorable
1-2
OA Rounds
1y 4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
68 granted / 98 resolved
+9.4% vs TC avg
Strong +39% interview lift
Without
With
+38.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
18 currently pending
Career history
115
Total Applications
across all art units

Statute-Specific Performance

§101
13.0%
-27.0% vs TC avg
§103
36.2%
-3.8% vs TC avg
§102
17.3%
-22.7% vs TC avg
§112
29.9%
-10.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 98 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim 1 is under examination. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 1 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. There is insufficient antecedent basis for the following limitations in the claim: Claim 1, line 1, “the likelihood of the presence” Claim 1, line 3, “providing the CO2 measurement data concerning the end-tidal partial pressure” Claim 1, line 6, “the value of the Sokolow-Lyon index, the value of the S wave in V5, the value” Claim 1, line 7, “of the R wave in V4 and the value of the angle of the QRS axis from the ECG” Claim 1, line 10, “determining a score value”, however, it is unclear if the score value S is the same as “a score value (S)” in line 1 or not. For the purpose of examination, it is interpreted as the same. Claim 1, lines 18-19 recites “if PetCO2 is greater than or equal to G1, S is equal to 1 if PetCO2 is less than G1, the method is continued in step lllb” However, it is unclear if the PetCO2 is the same as line 17 PetCO2 or not. For the purpose of examination, it is interpreted as the same. Claim 1, lines 22-24 recites “if Sokolow-Lyon index is greater than or equal to G2, S is equal to 1, if Sokolow-Lyon index < G2, the method is continued in step Ille”. However, it is unclear if it is referring to the same Sokolow-Lyon index in line 20. For the purpose of examination, it is interpreted as the same. Claim 1, lines 26-27 recites “if S wave in V5 is greater than or equal to G3, S is equal to 1, if S wave in V5 < G3, the method is continued in step llld”. However, it is unclear if it is referring to the same S wave in line in line 25. For the purpose of examination, it is interpreted as the same. Claim 1, lines 29-30 recites “if R wave in V2 is less than G4, S is equal to 1, if R wave in V2 is greater than or equal to G4, the method is”. However, it is unclear if it is referring to the same R wave in line in line 28. For the purpose of examination, it is interpreted as the same. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 1 is rejected under 35 U.S.C. 101 because the claimed invention is directed to abstract idea without significantly more. Step 1 of the subject matter eligibility test (see MPEP 2106.03). Claim 1 is directed to a “method”, which describes one of the four statutory categories of patentable subject matter, i.e., a process. Step 2A of the subject matter eligibility test (see MPEP 2106.04) Prong one: Claim 1 recites abstract idea, as follows: “…providing the CO2 measurement data concerning the end-tidal partial pressure of CO2 (PetCO2) of the person (P) over a period (t); II. providing ECG measurement data of the person (P) and determining at least the value of the Sokolow-Lyon index, the value of the S wave in V5, the value of the R wave in V4 and the value of the angle of the QRS axis from the ECG measurement data of said person (P) as dynamic clinical parameter (P1) over the same period (t) as in step I; and III. determining a score value (S) for the likelihood of the presence of a pulmonary hypertension in said person from the CO2 measurement data concerning the end- tidal partial pressure of CO2 (PetCO2) from step I and at least the ECG measurement data as dynamic clinical parameters (P1) from step II in the following substeps, where S equal to 0 means a high likelihood of a pulmonary hypertension (PH) and S equal to 1 means a low likelihood of a pulmonary hypertension (PH);a. comparing the PetCO2 from step I with a limit value G1,e if PetCO2 is greater than or equal to G1, S is equal to 1," if PetCO2 is less than G1, the method is continued in step IlIb, b. comparing the value of the Sokolow-Lyon index from step II with a limit value G2," if Sokolow-Lyon index is greater than or equal to G2, S is equal to 1," if Sokolow-Lyon index < G2, the method is continued in step IlIc, c. comparing the value of the S wave in V5 from step II with a limit value G3, " if S wave in V5 is greater than or equal to G3, S is equal to 1, " if S wave in V5 < G3, the method is continued in step Illd, d. comparing the value of the R wave in V4 from step II with a limit value G4, " if R wave in V2 is less than G4, S is equal to 1, " if R wave in V2 is greater than or equal to G4, the method is continued in step Ille, e. comparing the value of the angle of the QRS axis from step II with a limit value G5,e if angle of the QRS axis is less than G5, S is equal to 1, " if angle of the QRS axis is less than or equal to G5, S is equal to 0.” Based on the broadest reasonable interpretation, providing CO2 measurement data, providing ECG measurement data, determining a score value S, comparing PetCO2, comparing Sokolow-Lyon index, comparing S wave, comparing R wave, comparing the angle value of the QRS axis can be done mentally with the aid of a pen and paper. A person can provide a CO2 measurement data and ECG measurement data by drawing the data on a pencil or writing down the measurement values and time in a table. A person can then compare the PetCO2, Sokolow-Lyon index, S wave, R wave, the angle value of the QRS axis, by observing the numerical value written on a paper, and determining if it is greater, less than, or equal to a limit. Prong two: Claim 1 does not include any additional elements. Therefore, Claim 1 is ineligible at step 2A, prong two. Allowable Subject Matter Claim 1 would be allowable if rewritten to overcome the 112 and 101 rejections. The following is a statement of reasons for the indication of allowable subject matter: the closest prior art of record is US20180296126A1 (Anderson et. al), hereto referred as Anderson. Anderson teaches a method for determining score S for PH likelihood (Abstract, “Systems and methods for estimating a ventilatory threshold for a patient and estimating likelihood of pulmonary arterial hypertension are provided”); Use of binary convention, as in S equal to 0 means a high likelihood of a pulmonary hypertension (PH) and S equal to 1 means a low likelihood of a pulmonary hypertension (PH) ([0159]-[0161], “If TotalScore<=1 then PAH Unlikely, IF TotalScore between 1 and 3 then Consider PAH, If TotalScore between 3 and 5 then PAH likely”) Providing PetCO2 continuously over a period ([0006], “determining a score based upon end-tidal partial pressure of carbon dioxide (PetCO2) and minute ventilation/carbon dioxide production relationship (VE/VCO2) at the determined ventilatory threshold”; Fig. 2) Comparing PetCO2 from step I with a limit value G1 ([0151]-[0154], “IF PetCO2atVT>=37 then PetCO2Score=0; If PetCO2aNT between 30 and 37 PetCO2Score=1; If PetCO2atVT between 20 and 30 PetCO2Score=2; Otherwise PetCO2Score=3.”) However, Anderson does not teach determining at least the value of the Sokolow-Lyon index from ECG measurement data, comparing the value of the Sokolow-Lyon index from step II with a limit value G2, comparing the value of the S wave in V5 from step II with a limit value G3, comparing the value of the R wave in V4 from step II with a limit value G4, comparing the value of the angle of the QRS axis from step II with a limit value G5, along with other claimed steps or elements. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ELINA S JANG whose telephone number is (571)272-7019. The examiner can normally be reached M-F 9:00 am - 6:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ELINA SOHYUN JANG/Examiner, Art Unit 3791 /JENNIFER ROBERTSON/Supervisory Patent Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Oct 17, 2024
Application Filed
Aug 13, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12733821
IMPLANTABLE CEREBRAL SENSING DEVICES AND SYSTEMS AND METHODS RELATED THERETO
4y 11m to grant Granted Sep 15, 2026
Patent 12728017
Systems And Methods For Joint Balancing
5y 1m to grant Granted Sep 08, 2026
Patent 12690815
CARDIAC IMPLANT DEVICES WITH INTEGRATED PRESSURE SENSING
5y 1m to grant Granted Jul 28, 2026
Patent 12678088
BRAIN WAVE CLASSIFICATION WITH BENEFICIAL ACTION RECOMMENDATIONS
3y 4m to grant Granted Jul 14, 2026
Patent 12661066
ADJUSTABLE MEDICAL GARMENT WITH PRESSURE CONTROL
4y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
69%
Grant Probability
99%
With Interview (+38.7%)
3y 3m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 98 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month